Pacgen Life Science Co. (PBS.V) (PBS) Stock Price, News & Analysis

Company Overview

Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.03 to C$0.03
• 50-Day Range: C$0.03 to C$0.03
• 52-Week Range: C$0.01 to C$0.05
• Volume: 2,000 shs
• Average Volume: 63,601 shs
• Market Capitalization: C$1.94 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: CVE:PBS
• CIK: N/A
• Web: www.pacgenlife.com
• Phone: +1-604-4364388
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 78.48
• Current Ratio: 0.81
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: C$302.08 thousand
• Price / Sales: 6.44
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 30.00
• Book Value: C$0.00 per share
• Price / Book: -30.00

Miscellaneous

• Outstanding Shares: 64,816,000
• Free Float: N/A
• Market Cap: C$1.94 million
• Optionable: Not Optionable
• Beta: N/A